The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amphotericin B for Injection Market Research Report 2025
Synopsis
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Amphotericin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amphotericin B for Injection include Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amphotericin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B for Injection.
The Amphotericin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Amphotericin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
SPH New Asia Pharmaceuticals
North China Pharmaceutical
Cspc Holdings
Jemincare
Segment by Type
Common Formulation
Liposome Formulation
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amphotericin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amphotericin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Amphotericin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amphotericin B for Injection include Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amphotericin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B for Injection.
The Amphotericin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Amphotericin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
SPH New Asia Pharmaceuticals
North China Pharmaceutical
Cspc Holdings
Jemincare
Segment by Type
Common Formulation
Liposome Formulation
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amphotericin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amphotericin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amphotericin B for Injection Market Overview
1.1 Product Definition
1.2 Amphotericin B for Injection by Type
1.2.1 Global Amphotericin B for Injection Market Value Comparison by Type (2024-2030)
1.2.2 Common Formulation
1.2.3 Liposome Formulation
1.3 Amphotericin B for Injection by Application
1.3.1 Global Amphotericin B for Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Amphotericin B for Injection Market Size Estimates and Forecasts
1.4.1 Global Amphotericin B for Injection Revenue 2019-2030
1.4.2 Global Amphotericin B for Injection Sales 2019-2030
1.4.3 Global Amphotericin B for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amphotericin B for Injection Market Competition by Manufacturers
2.1 Global Amphotericin B for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amphotericin B for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amphotericin B for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Amphotericin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amphotericin B for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amphotericin B for Injection, Product Type & Application
2.7 Global Key Manufacturers of Amphotericin B for Injection, Date of Enter into This Industry
2.8 Global Amphotericin B for Injection Market Competitive Situation and Trends
2.8.1 Global Amphotericin B for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amphotericin B for Injection Players Market Share by Revenue
2.8.3 Global Amphotericin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amphotericin B for Injection Market Scenario by Region
3.1 Global Amphotericin B for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amphotericin B for Injection Sales by Region: 2019-2030
3.2.1 Global Amphotericin B for Injection Sales by Region: 2019-2024
3.2.2 Global Amphotericin B for Injection Sales by Region: 2025-2030
3.3 Global Amphotericin B for Injection Revenue by Region: 2019-2030
3.3.1 Global Amphotericin B for Injection Revenue by Region: 2019-2024
3.3.2 Global Amphotericin B for Injection Revenue by Region: 2025-2030
3.4 North America Amphotericin B for Injection Market Facts & Figures by Country
3.4.1 North America Amphotericin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amphotericin B for Injection Sales by Country (2019-2030)
3.4.3 North America Amphotericin B for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amphotericin B for Injection Market Facts & Figures by Country
3.5.1 Europe Amphotericin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amphotericin B for Injection Sales by Country (2019-2030)
3.5.3 Europe Amphotericin B for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amphotericin B for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Amphotericin B for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amphotericin B for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Amphotericin B for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Amphotericin B for Injection Market Facts & Figures by Country
3.7.1 Latin America Amphotericin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amphotericin B for Injection Sales by Country (2019-2030)
3.7.3 Latin America Amphotericin B for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Amphotericin B for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Amphotericin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amphotericin B for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amphotericin B for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amphotericin B for Injection Sales by Type (2019-2030)
4.1.1 Global Amphotericin B for Injection Sales by Type (2019-2024)
4.1.2 Global Amphotericin B for Injection Sales by Type (2025-2030)
4.1.3 Global Amphotericin B for Injection Sales Market Share by Type (2019-2030)
4.2 Global Amphotericin B for Injection Revenue by Type (2019-2030)
4.2.1 Global Amphotericin B for Injection Revenue by Type (2019-2024)
4.2.2 Global Amphotericin B for Injection Revenue by Type (2025-2030)
4.2.3 Global Amphotericin B for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Amphotericin B for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amphotericin B for Injection Sales by Application (2019-2030)
5.1.1 Global Amphotericin B for Injection Sales by Application (2019-2024)
5.1.2 Global Amphotericin B for Injection Sales by Application (2025-2030)
5.1.3 Global Amphotericin B for Injection Sales Market Share by Application (2019-2030)
5.2 Global Amphotericin B for Injection Revenue by Application (2019-2030)
5.2.1 Global Amphotericin B for Injection Revenue by Application (2019-2024)
5.2.2 Global Amphotericin B for Injection Revenue by Application (2025-2030)
5.2.3 Global Amphotericin B for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Amphotericin B for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Amphotericin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Amphotericin B for Injection Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 SPH New Asia Pharmaceuticals
6.2.1 SPH New Asia Pharmaceuticals Company Information
6.2.2 SPH New Asia Pharmaceuticals Description and Business Overview
6.2.3 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolio
6.2.5 SPH New Asia Pharmaceuticals Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Company Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Amphotericin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 North China Pharmaceutical Amphotericin B for Injection Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 Cspc Holdings
6.4.1 Cspc Holdings Company Information
6.4.2 Cspc Holdings Description and Business Overview
6.4.3 Cspc Holdings Amphotericin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cspc Holdings Amphotericin B for Injection Product Portfolio
6.4.5 Cspc Holdings Recent Developments/Updates
6.5 Jemincare
6.5.1 Jemincare Company Information
6.5.2 Jemincare Description and Business Overview
6.5.3 Jemincare Amphotericin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jemincare Amphotericin B for Injection Product Portfolio
6.5.5 Jemincare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amphotericin B for Injection Industry Chain Analysis
7.2 Amphotericin B for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amphotericin B for Injection Production Mode & Process
7.4 Amphotericin B for Injection Sales and Marketing
7.4.1 Amphotericin B for Injection Sales Channels
7.4.2 Amphotericin B for Injection Distributors
7.5 Amphotericin B for Injection Customers
8 Amphotericin B for Injection Market Dynamics
8.1 Amphotericin B for Injection Industry Trends
8.2 Amphotericin B for Injection Market Drivers
8.3 Amphotericin B for Injection Market Challenges
8.4 Amphotericin B for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Amphotericin B for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amphotericin B for Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Amphotericin B for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amphotericin B for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amphotericin B for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amphotericin B for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amphotericin B for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amphotericin B for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amphotericin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amphotericin B for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amphotericin B for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Amphotericin B for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amphotericin B for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amphotericin B for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amphotericin B for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Amphotericin B for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Amphotericin B for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Amphotericin B for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Amphotericin B for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amphotericin B for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Amphotericin B for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amphotericin B for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Amphotericin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Amphotericin B for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Amphotericin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amphotericin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amphotericin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amphotericin B for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amphotericin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amphotericin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amphotericin B for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amphotericin B for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amphotericin B for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amphotericin B for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amphotericin B for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amphotericin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amphotericin B for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amphotericin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Amphotericin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Amphotericin B for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Amphotericin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Amphotericin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amphotericin B for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Amphotericin B for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Amphotericin B for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Amphotericin B for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amphotericin B for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amphotericin B for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Amphotericin B for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Amphotericin B for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Amphotericin B for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Amphotericin B for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Amphotericin B for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Amphotericin B for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Amphotericin B for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amphotericin B for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amphotericin B for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Amphotericin B for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Amphotericin B for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Amphotericin B for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Gilead Sciences Amphotericin B for Injection Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. SPH New Asia Pharmaceuticals Company Information
Table 76. SPH New Asia Pharmaceuticals Description and Business Overview
Table 77. SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. SPH New Asia Pharmaceuticals Amphotericin B for Injection Product
Table 79. SPH New Asia Pharmaceuticals Recent Developments/Updates
Table 80. North China Pharmaceutical Company Information
Table 81. North China Pharmaceutical Description and Business Overview
Table 82. North China Pharmaceutical Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. North China Pharmaceutical Amphotericin B for Injection Product
Table 84. North China Pharmaceutical Recent Developments/Updates
Table 85. Cspc Holdings Company Information
Table 86. Cspc Holdings Description and Business Overview
Table 87. Cspc Holdings Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Cspc Holdings Amphotericin B for Injection Product
Table 89. Cspc Holdings Recent Developments/Updates
Table 90. Jemincare Company Information
Table 91. Jemincare Description and Business Overview
Table 92. Jemincare Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Jemincare Amphotericin B for Injection Product
Table 94. Jemincare Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Amphotericin B for Injection Distributors List
Table 98. Amphotericin B for Injection Customers List
Table 99. Amphotericin B for Injection Market Trends
Table 100. Amphotericin B for Injection Market Drivers
Table 101. Amphotericin B for Injection Market Challenges
Table 102. Amphotericin B for Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Amphotericin B for Injection
Figure 2. Global Amphotericin B for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amphotericin B for Injection Market Share by Type: 2023 & 2030
Figure 4. Common Formulation Product Picture
Figure 5. Liposome Formulation Product Picture
Figure 6. Global Amphotericin B for Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Amphotericin B for Injection Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Amphotericin B for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Amphotericin B for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Amphotericin B for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Amphotericin B for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Amphotericin B for Injection Report Years Considered
Figure 16. Amphotericin B for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Amphotericin B for Injection Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Amphotericin B for Injection Players: Market Share by Revenue in Amphotericin B for Injection in 2023
Figure 19. Amphotericin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Amphotericin B for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Amphotericin B for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Amphotericin B for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Amphotericin B for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Amphotericin B for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Amphotericin B for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Amphotericin B for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Amphotericin B for Injection Sales Market Share by Country (2019-2030)
Figure 42. Mexico Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Amphotericin B for Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Amphotericin B for Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Amphotericin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Amphotericin B for Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Amphotericin B for Injection by Type (2019-2030)
Figure 53. Global Amphotericin B for Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Amphotericin B for Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Amphotericin B for Injection by Application (2019-2030)
Figure 56. Global Amphotericin B for Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Amphotericin B for Injection Value Chain
Figure 58. Amphotericin B for Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
